Before you sell to, join or invest in Orbit Genomics, Inc.
MentionFox check on Orbit Genomics, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/orbit-genomics-inc-form-d-25000001
Check Orbit Genomics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Orbit Genomics, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Orbit Genomics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-03-18.
Orbit Genomics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on March 18, 2025. The filing reports $780K sold. Its industry group is Biotechnology. It names Elizabeth (Dede) Willis (Executive Officer, Director), Harold (Skip) Garner (Executive Officer, Director), Julie Silber (Director) (SEC Form D/A, March 18, 2025).
Is this your company?
Sell to companies like Orbit Genomics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Orbit Genomics, Inc.
Free to see. No signup.
More on the people and the money behind Orbit Genomics, Inc., from the filings we hold.
Biotechnology raises by companies based in Colorado, filed within 90 days of this one, largest first.
Get an email when Orbit Genomics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Orbit Genomics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Orbit Genomics, Inc. →Get the full cited report on Orbit Genomics, Inc.
What the filing shows about Orbit Genomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Orbit Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Orbit Genomics, Inc.'s address as 4665 Nautilus Ct S, Ste 300, Boulder, CO 80301.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-07-28: the amount sold changed from $530,000 to $780,000; the number of investors changed from 11 to 15. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Orbit Genomics, Inc. is a registered filer with the SEC (CIK 2058369) and has filed since 2025-03-18. 2 filings are on record, the latest on 2025-07-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Orbit Genomics, Inc.'s Form D of 2025-03-18 names Elizabeth (Dede) Willis, Harold (Skip) Garner, Julie Silber and 1 more as its officers, directors or promoters.
Its new offerings report $530K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Elizabeth (Dede) Willis is named as Executive Officer and Director on the Form D that Orbit Genomics, Inc. filed with the SEC on 18 March 2025, one of 4 people that filing names.
Harold (Skip) Garner is named as Executive Officer and Director on the Form D that Orbit Genomics, Inc. filed with the SEC on 18 March 2025, one of 4 people that filing names.
Julie Silber is named as Director on the Form D that Orbit Genomics, Inc. filed with the SEC on 18 March 2025, one of 4 people that filing names.
Oerum Mikael is named as Director on the Form D that Orbit Genomics, Inc. filed with the SEC on 18 March 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-03-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Orbit Genomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Orbit Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Orbit Genomics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Orbit Genomics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Orbit Genomics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Orbit Genomics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Denver and Boulder
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/orbit-genomics-inc-form-d-25000001